Status:
TERMINATED
Combined Optical and Infrared Imaging for Early Prediction of Erythema During Breast and Chestwall Radiotherapy
Lead Sponsor:
Nova Scotia Health Authority
Conditions:
Breast Cancer
Eligibility:
FEMALE
Phase:
NA
Brief Summary
The aim of this study is to develop a computer model, based on photographs and heat images of patients' skin, to provide early prediction of painful reddening of the skin during radiotherapy treatment...
Detailed Description
There is currently no reliable tool to quantify and detect erythema of the skin during radiotherapy. This side-effect may lead to painful moist desquamation, and eventually permanent delayed side effe...
Eligibility Criteria
Inclusion
- \- All female patients referred for adjuvant radiotherapy following breast conserving surgery/mastectomy.
Exclusion
- Patients with known skin issues (e.g. dermatomyositis, rosacea)
- Patients with excessive risk of skin recurrence, including T4d
- Patients with locally advanced breast cancer.
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 14 2021
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT04363892
Start Date
July 1 2020
End Date
June 14 2021
Last Update
August 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dalhousie University - Radiation Oncology Department
Halifax, Nova Scotia, Canada, B3H 4H7